文献速递糖尿病

血清血管生成素样蛋白6、2型糖尿病风险与高血糖反应:一项前瞻性队列研究

Serum Angiopoietin-like Protein 6, Risk of Type 2 Diabetes, and Response to Hyperglycemia: A Prospective Cohort Study.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

该前瞻性队列研究纳入1103例基线无糖尿病的成人,每2年随访一次,随访4.22年间113例(10.2%)发生糖尿病;血清ANGPTL6与糖尿病发病呈负相关(校正HR 0.77,P=0.042),但糖尿病前期者ANGPTL6更高且在OGTT中升高;HepG2细胞中葡萄糖而非胰岛素诱导ANGPTL6表达,高脂饮食小鼠肝脏ANGPTL6表达及血清浓度显著高于标准饲料小鼠(均P<0.05)。

要点

  • 基线无糖尿病的1103例成人随访4.22年,113例(10.2%)发生糖尿病。
  • 血清ANGPTL6与糖尿病发病呈负相关,校正HR 0.77(P=0.042)。
  • 糖尿病前期者血清ANGPTL6更高(P=0.018),OGTT中ANGPTL6升高。

核心结论

  • 高血清ANGPTL6水平与人类较低的糖尿病发病率相关。
  • ANGPTL6响应高血糖而表达和分泌,以维持葡萄糖稳态。

研究设计与样本

  • 前瞻性队列研究,纳入基线无糖尿病的成人,每2年随访一次至发生糖尿病。
  • 基线及口服葡萄糖耐量试验(OGTT)期间测定血清ANGPTL6浓度。
  • 使用HepG2肝细胞系和饮食诱导肥胖小鼠模型评估ANGPTL6对高血糖和代谢综合征的反应。

主要发现

  • 共招募1103例基线无糖尿病参与者,随访4.22年间113例(10.2%)发生糖尿病。
  • 血清ANGPTL6与糖尿病发病率呈负相关(校正风险比0.77,P=0.042)。
  • 糖尿病前期参与者血清ANGPTL6水平更高(P=0.018),且在OGTT期间升高。
  • HepG2细胞中葡萄糖而非胰岛素处理诱导ANGPTL6表达。
  • 高脂饮食小鼠肝脏ANGPTL6表达及血清ANGPTL6浓度均显著高于标准饲料小鼠(均P<0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Angiopoietin-like protein 6 (ANGPTL6) is a hepatokine that improves insulin sensitivity in animals. However, serum ANGPTL6 concentration was found to be higher in human participants with diabetes or metabolic syndrome in cross-sectional studies, implying that ANGPTL6 may be induced to counteract hyperglycemia. OBJECTIVE: To investigate whether serum ANGPTL6 can predict incident diabetes and explore whether glucose or insulin can regulate ANGPTL6 expression and secretion. DESIGN: This cohort study included adults without diabetes at baseline who were followed every 2 years for incident diabetes. Serum ANGPTL6 concentrations were measured at baseline and during oral glucose tolerance tests (OGTTs). A hepatic cell line, HepG2, and diet-induced obesity mouse model were used to evaluate the response of ANGPTL6 expression and secretion to hyperglycemia and the metabolic syndrome. RESULTS: We recruited 1103 participants without diabetes at baseline. During the 4.22-year follow-up, 113 (10.2%) participants developed incident diabetes. Serum ANGPTL6 was negatively associated with the incidence of diabetes (adjusted hazard ratio, 0.77; P = 0.042). However, serum ANGPTL6 level was higher in participants with prediabetes (P = 0.018) and was elevated during OGTT. In HepG2 cells, treatment with glucose, but not insulin, induced ANGPTL6 expression. Hepatic ANGPTL6 expression and serum ANGPTL6 concentrations were significantly higher in mice fed with a high-fat diet than in those fed with a standard chow (both P < 0.05). CONCLUSION: A high serum ANGPTL6 level is associated with a low incidence of diabetes in humans. ANGPTL6 is expressed and secreted in response to hyperglycemia to maintain glucose homeostasis.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Fan KC, Wu HT, Wei JN, et al. Serum Angiopoietin-like Protein 6, Risk of Type 2 Diabetes, and Response to Hyperglycemia: A Prospective Cohort Study. J Clin Endocrinol Metab. 2020. PMID: 32123920. doi:10.1210/clinem/dgaa103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。